Low-carbohydrate diets reduce cardiovascular risk factor levels in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials
Frontiers in Nutrition · 26.08.2025 · 12
DOI: 10.3389/fnut.2025.1626352 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Nutrition, online erschienen am 26.08.2025. Verfasst von Shanshan Pi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Low-carbohydrate diets (LCDs) are increasingly advocated for the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD); however, their cardiovascular safety profile remains controversial. This analysis aims to evaluate the effects of LCDs on cardiovascular risk factors in MASLD patients.
Methods
PubMed, Cochrane Library, Web of Science, and Scopus were searched from inception to March 19, 2025. Two reviewers independently conducted data extraction. Meta-analyses were performed using fixed-effects or random-effects models, as determined by the heterogeneity of the included studies. Outcomes included blood pressure, glycemic markers, lipid profiles, and anthropometric indicators. Subgroup analyses explored carbohydrate thresholds (<26% vs. ≥26%) and intervention durations (<24 weeks vs. ≥24 weeks).
Results
Sixteen RCTs comprising 1,056 participants were included. LCDs significantly reduced glycated hemoglobin (HbA1c: SMD, −0.27; 95% CI, −0.47 to −0.07), triglyceride (TG: SMD, −0.20; 95% CI, −0.34 to −0.06), body weight (SMD, −0.19; 95% CI, −0.36 to −0.03), and body mass index (BMI: SMD, −0.28; 95% CI, −0.42 to −0.14). Stricter carbohydrate restriction (<26% energy) further improved systolic/diastolic blood pressure, homeostatic model assessment insulin resistance index (HOMA-IR), HbA1c, TG, body weight, BMI, and waist circumference. Short-term interventions (<24 weeks) lowered HbA1c, TG, and BMI.
Conclusion
This systematic review and meta-analysis found that LCDs are associated with improvements in cardiometabolic risk factors among patients with MASLD. Furthermore, short-term implementation of a strict carbohydrate-restricted dietary regimen may yield additional clinical benefits. Future research should prioritize: standardized nutrient assessment, enhanced adherence strategies, and cardiovascular endpoint trials.
Systematic review registration
PROSPERO: CRD42024603432; https://www.crd.york.ac.uk/PROSPERO/view/CRD42024603432 .
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.
- Beijing University of Chinese Medicine, Beijing, China.
- Department of Cardiology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
- Liver Diseases Academy of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Zitieren
APA
Pi, S., Zhang, S., Zhang, J., Guo, Y., Li, Y., Deng, J., & Du, H. (2025). Low-carbohydrate diets reduce cardiovascular risk factor levels in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1626352
Vancouver
Pi S, Zhang S, Zhang J, Guo Y, Li Y, Deng J, et al. Low-carbohydrate diets reduce cardiovascular risk factor levels in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Nutrition. 2025;12. doi:10.3389/fnut.2025.1626352
BibTeX
@article{Pi2025,
author = {Pi, Shanshan and Zhang, Shuwen and Zhang, Junjie and Guo, Yi and Li, Yue and Deng, Jinyan and Du, Hongbo},
title = {Low-carbohydrate diets reduce cardiovascular risk factor levels in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials},
journal = {Frontiers in Nutrition},
year = {2025},
volume = {12},
doi = {10.3389/fnut.2025.1626352}
}
EUVIMED